ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 127 filers reported holding ANIKA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $65 | -29.3% | 3,500 | -1.5% | 0.00% | -25.0% |
| Q2 2023 | $92 | -10.7% | 3,554 | -0.6% | 0.00% | 0.0% |
| Q1 2023 | $103 | -2.8% | 3,575 | -0.3% | 0.00% | -20.0% |
| Q4 2022 | $106 | -99.9% | 3,587 | -9.0% | 0.01% | +25.0% |
| Q3 2022 | $94,000 | -5.1% | 3,941 | -11.6% | 0.00% | +33.3% |
| Q2 2022 | $99,000 | -10.0% | 4,456 | +1.3% | 0.00% | 0.0% |
| Q1 2022 | $110,000 | -39.2% | 4,399 | -12.9% | 0.00% | -25.0% |
| Q4 2021 | $181,000 | -15.4% | 5,049 | +0.6% | 0.00% | -20.0% |
| Q3 2021 | $214,000 | -5.7% | 5,020 | -4.2% | 0.01% | +25.0% |
| Q2 2021 | $227,000 | -37.6% | 5,240 | -41.3% | 0.00% | -42.9% |
| Q1 2021 | $364,000 | +111.6% | 8,921 | +134.5% | 0.01% | +75.0% |
| Q4 2020 | $172,000 | +27.4% | 3,804 | 0.0% | 0.00% | +33.3% |
| Q3 2020 | $135,000 | -6.2% | 3,804 | 0.0% | 0.00% | -25.0% |
| Q2 2020 | $144,000 | – | 3,804 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caligan Partners LP | 591,675 | $17,513,580 | 14.58% |
| Trigran Investments, Inc. | 1,564,541 | $46,310,413 | 4.64% |
| DIKER MANAGEMENT LLC | 22,458 | $664,757 | 0.77% |
| Virtus Fund Advisers, LLC | 3,490 | $103,304 | 0.74% |
| Portolan Capital Management | 207,900 | $6,153,840 | 0.61% |
| Virtus Investment Advisers, Inc. | 16,086 | $476,146 | 0.32% |
| Ranger Investment Management | 140,205 | $4,150,068 | 0.31% |
| BOOTHBAY FUND MANAGEMENT, LLC | 367,510 | $10,878,296 | 0.25% |
| Riverwater Partners LLC | 9,778 | $289,429 | 0.25% |
| Legato Capital Management LLC | 7,556 | $223,658 | 0.04% |